Novartis (NVS)
(Delayed Data from NYSE)
$110.32 USD
+0.39 (0.35%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $110.30 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth A Momentum C VGM
Brokerage Reports
0 items in cart
Novartis AG [NVS]
Reports for Purchase
Showing records 341 - 360 ( 478 total )
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Comprehensive Technical and Fundamental Analysis for NVS.
Provider: Stock Traders Daily
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Cannabis - Where are we and where are we going?
Provider: Edison Investment Research Limited
Analyst: JACOBS M
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Countdown to EASL Begins: Presentation Titles Released
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Immuno-Oncology Key Opinion Leader Conference Call Recap
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R